Is VRDN or VTVT more undervalued in 2026?

CirclFi compares Viridian Therapeutics, Inc. (VRDN) and vTv Therapeutics Inc. (VTVT) using 13 institutional-grade valuation models. VRDN has a Quality of Company score of 6.3/10 while VTVT scores 6.0/10.

Which is a better buy — VRDN or VTVT?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do VRDN and VTVT valuations compare?

VRDN at $17.62 and VTVT at $33.35 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

VRDN vs VTVT Valuation Comparison 2026 — Intrinsic Value Analysis

VRDN

Pharmaceutical Preparations

Viridian Therapeutics, Inc.

Quality

6.3

out of 10

Value Trap

SAFE

Price

$17.62

Last close

Models

9/13

Active

VTVT

Pharmaceutical Preparations

vTv Therapeutics Inc.

Quality

6.0

out of 10

Value Trap

WARN

Price

$33.35

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	VRDN Fair Value	VRDN Upside	VTVT Fair Value	VTVT Upside
Bayesian DCF	Intrinsic	$5.54	-68.5%	$34.81	+4.4%
Earnings Power Value	Intrinsic	—	—	$30.82	-7.6%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$6.24	-64.6%	$31.09	-6.8%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for VRDN vs VTVT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

VRDN vs VTVT — Which Stock Is More Undervalued?

VRDN scores higher with a 6.3/10 quality rating vs VTVT's 6.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Viridian Therapeutics, Inc. (VRDN) and vTv Therapeutics Inc. (VTVT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

VRDN currently trades at $17.62 with a QOC of 6.3/10, while VTVT trades at $33.35 with a QOC of 6.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).